Literature DB >> 25605214

DNA ligase4 as a prognostic marker in nasopharyngeal cancer patients treated with radiotherapy.

Dong Hyun Kim1, Sung Yong Oh, So Yeon Kim, Seul Lee, Myeong Seok Koh, Ji Hyun Lee, Suee Lee, Sung-Hyun Kim, Heon Soo Park, Won Joo Hur, Jin Sook Jeong, Mi Ha Ju, Young Mi Seol, Young-Jin Choi, Joo Seop Chung, Hyo-Jin Kim.   

Abstract

BACKGROUND: The capability for DNA double-strand breaks (DSBs) repair is crucial for inherent radiosensitivity of tumor and normal cells. We have investigated the clinicopathologic significance of DNA repair gene expression in nasopharyngeal (NP) carcinoma.
MATERIALS AND METHODS: A total of 65 NP cancer patients who received radiotherapy were included. The immunopositivity to Ku 70, DNA-PKcs, MRN, RAD50, XRCC4, and LIG4 were examined in all tumor tissues.
RESULTS: The patients comprised 42 males and 23 females, with a median age of 56 years (range, 18-84). The expression levels of RAD50 (0,+1,+2,+3) were 27.7%, 32.3%, 21.5%, and 18.5%. LIG4 (±) were 43.1% and 56.9% respectively. The 5-year OS rate of patients with LIG4 (±) were 90% and 67.9%, respectively (p=0.035). The 5-year TTP rate of patients with LIG4 (±) were 75.9%, 55.5%, respectively (P=0.039).
CONCLUSIONS: Our results suggest the possibility of predicting the radiosensitivity of NP cancer by performing immunohistochemical analysis of LIG4.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25605214     DOI: 10.7314/apjcp.2014.15.24.10985

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.

Authors:  Jennifer Munkley; Teresa M Maia; Nekane Ibarluzea; Karen E Livermore; Daniel Vodak; Ingrid Ehrmann; Katherine James; Prabhakar Rajan; Nuno L Barbosa-Morais; David J Elliott
Journal:  F1000Res       Date:  2018-08-03

2.  Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.

Authors:  Reem Ali; Muslim Alabdullah; Mashael Algethami; Adel Alblihy; Islam Miligy; Ahmed Shoqafi; Katia A Mesquita; Tarek Abdel-Fatah; Stephen Yt Chan; Pei Wen Chiang; Nigel P Mongan; Emad A Rakha; Alan E Tomkinson; Srinivasan Madhusudan
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.